Nikolay Nifantiev

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Brigham and Women's Hospital, Inc., Biolitec Pharma Marketing Ltd, Ceramoptec Industries, Inc.. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolay Nifantiev. Retrieved from https://idiyas.com/inventor/nikolay-nifantiev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 58.3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 59(Granted Patents)

Company Filing History:

5 out of 1,428

The Brigham and Women's Hospital, Inc.

patents

3 out of 39

Biolitec Pharma Marketing Ltd

patents

3 out of 91

Ceramoptec Industries, Inc.

patents

4. 1 out of 69

Inje University Industry-Academic Cooperation Foundation

patents

Years Active: 2004-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428417 - Inhibitors of macrophage migration inhibitory factor (2025-09-30),

2. 11123416 - Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides (2021-09-21),

3. 10927101 - Neopetrosides A and B, and synthesis method thereof (2021-02-23),

4. 10034927 - Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides (2018-07-31),

5. 9474806 - Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides (2016-10-25),

6. 9216166 - Anti-microbial photodynamic therapy (2015-12-22),

7. 8815931 - Oral formulations for tetrapyrrole derivatives (2014-08-26),

8. 8580839 - Photosensitizer formulations and their use (2013-11-12),

9. 8492364 - Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides (2013-07-23),

10. 7825153 - Photosensitizer formulations and their use (2010-11-02),

11. 6949581 - Water-soluble mono-PEGylated tetrapyrrole derivatives for photodynamic therapy and method of production (2005-09-27),

12. 6777402 - Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture (2004-08-17),

Title: The Innovations of Nikolay Nifantiev: A Luminary in Synthetic Compounds

Introduction

Nikolay Nifantiev is a distinguished inventor based in Moscow, RU, holding an impressive portfolio of 11 patents. He has made significant contributions to the field of synthetic compounds, particularly in the development of innovative methods and compositions related to glucosamine oligosaccharides and pyridine nucleoside compounds.

Latest Patents

Among his latest patents, the invention titled "Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides" showcases his expertise in creating synthetic oligo-β-(1→6)-2-amino-2-deoxy-D-glucopyranosides. These innovative compositions are conjugated to carriers, providing novel applications in various industries.

Another remarkable patent is for "Neopetrosides A and B, and synthesis method thereof." This invention focuses on new pyridine nucleoside compounds obtained by fractionating extracts from marine sponges. Notably, Neopetroside A (NPS A) demonstrates the ability to activate oxidative phosphorylation and stimulate glycolysis, presenting possibilities for pharmaceutical compositions aimed at treating ischemic heart disease.

Career Highlights

Throughout his career, Nikolay Nifantiev has collaborated with renowned institutions and companies. Notable placements include working at Brigham and Women's Hospital and Ceramoptec Industries. His experience and research in these prestigious organizations have contributed significantly to his innovations and development of patented technologies.

Collaborations

Collaborating with remarkable individuals such as Gerald B. Pier and Yury Tsvetkov has further enriched Nifantiev's work. These partnerships have enabled him to enhance his research and inventions, leading to impactful advancements in the scientific community.

Conclusion

Nikolay Nifantiev’s contributions to synthetic compounds through his innovative patents highlight his role as a pioneer in the field. With a robust background and successful collaborations, he continues to push the boundaries of science and technology, shaping the future of therapeutic applications and innovations.

Profile summary based on public USPTO records.